Michaela Ott
Directeur/Membre du Conseil chez Medite Enterprise, Inc.
Profil
Michaela Ott is currently the Director at Medite Enterprise, Inc. She previously held the position of Chief Executive Officer at CytoCore, Inc. and was also the Managing Director at Medite GmbH.
Additionally, she was the Co-President at MEDITE GmbH from 2006 to 2017 and served as the Director at MEDITE Cancer Diagnostics, Inc. from 2017 to 2018.
Postes actifs de Michaela Ott
| Sociétés | Poste | Début |
|---|---|---|
Medite Enterprise, Inc.
 Medite Enterprise, Inc. Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite Enterprise, Inc. develops diagnostics and therapeutic medical devices. The company is based in Orlando, FL. Michael Egbert Ott has been the CEO of the company since 2013. Medite Enterprise was acquired by CytoCore, Inc. on April 04, 2014 for $342 million. | Directeur/Membre du Conseil | 01/01/2013 |
Anciens postes connus de Michaela Ott
| Sociétés | Poste | Fin |
|---|---|---|
| MEDITE CANCER DIAGNOSTICS INC | Directeur Général | 26/10/2016 |
Medite GmbH /Austria/
 Medite GmbH /Austria/ Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a company based in Salzburg, Austria. Medite GmbH develops diagnostics and therapeutic medical devices. | Directeur Général | 30/09/2017 |
MEDITE GmbH
 MEDITE GmbH Medical DistributorsDistribution Services Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a German company that develops diagnostics and therapeutic medical devices. The company is based in Niedersachsen, Germany. The CEO of the company is Elmar A. Dave. | President | 04/05/2017 |
CytoCore, Inc.
 CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEDITE CANCER DIAGNOSTICS INC | Health Technology |
| Entreprise privées | 4 |
|---|---|
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Health Technology |
Medite Enterprise, Inc.
Medite Enterprise, Inc. Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite Enterprise, Inc. develops diagnostics and therapeutic medical devices. The company is based in Orlando, FL. Michael Egbert Ott has been the CEO of the company since 2013. Medite Enterprise was acquired by CytoCore, Inc. on April 04, 2014 for $342 million. | Health Technology |
MEDITE GmbH
MEDITE GmbH Medical DistributorsDistribution Services Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a German company that develops diagnostics and therapeutic medical devices. The company is based in Niedersachsen, Germany. The CEO of the company is Elmar A. Dave. | Distribution Services |
Medite GmbH /Austria/
Medite GmbH /Austria/ Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a company based in Salzburg, Austria. Medite GmbH develops diagnostics and therapeutic medical devices. | Health Technology |
